OPPM
ARRY

Opus Point Partners Management’s Array Biopharma Inc ARRY Stock Holding History

Opus Point Partners Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-250,000
Closed -$1.14M – 67
2015
Q3 		$1.14M Sell
250,000
-70,000
-22% -$415K 0.63% 29
2015
Q2 		$2.31M Buy
320,000
+120,000
+60% +$886K 1.83% 24
2015
Q1 		$1.47M Hold
200,000
– – 1.24% 27
2014
Q4 		$946K Buy
+200,000
New +$791K 0.94% 32

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Opus Point Partners Management's ARRY Position: Q4 2015 in Review

Opus Point Partners Management sold out of Array Biopharma Inc (ARRY) in Q4 2015, closing a stake of 250,000 shares — an estimated $1.14M sold.

Opus Point Partners Management first reported a position in ARRY in Q4 2014 and held it in 4 quarters. The position peaked at $2.31M in Q2 2015. 151 funds tracked by Wall St. Rank hold ARRY as of Q4 2015.

  • Opus Point Partners Management reported no remaining Array Biopharma Inc position as of Q4 2015 after selling out during the quarter.
  • Opus Point Partners Management sold 250,000 Array Biopharma Inc shares in Q4 2015, an estimated $1.14M.
  • Opus Point Partners Management first reported a position in Array Biopharma Inc in Q4 2014 and held it in 4 quarters.
  • Opus Point Partners Management's Array Biopharma Inc position peaked at $2.31M in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2015.

Based on Opus Point Partners Management's 13F filing for Q4 2015, filed 16 Feb 2016.